10-Q/A

                   
 
 


 
                     SECURITIES AND EXCHANGE COMMISSION 
                           Washington, D.C.  20549 
 
                                    FORM 10-Q/A
                                 (Amendment no. 1) 
 
                  Quarterly Report under Section 13 or 15(d) of 
                     The Securities Exchange Act of 1934 
 
 
For quarter ended:  March 31, 1995   Commission File No.  0-11178 
 
                        UTAH MEDICAL PRODUCTS, INC. 
           (Exact name of Registrant as specified in its charter) 
 
         UTAH                                       87-0342734 
 (State or other jurisdiction                       IRS Employer 
incorporation or organization)                 Identification No. 
 
 
                             7043 South 300 West 
                             Midvale Utah 84047 
                   (Address of principal executive offices) 
 
 
Registrant's telephone number:(801) 566-1200 
 
 
 
Indicate by check mark whether the registrant (1) has filed all  
reports required to be filed by Sections 13 or 15(d) of the  
Securities Exchange Act of 1934 during the preceding 12 months  
(or for such shorter period that the registrant was required to  
file such reports); and (2) has been subject to such filing  
requirements for the past 90 days.  Yes (X)  No ( ) 
 
The number of shares outstanding of the registrant's common stock as  
of May 12, 1995:  9,785,135 
 
 
SIGNATURES 
 
          Pursuant to the requirements of the Securities Exchanges Act  
of 1934, the registrant has duly caused this amendment to be signed on  
its behalf by the undersigned thereunto duly authorized. 
 
 
                              UTAH MEDICAL PRODUCTS, INC. 
                              REGISTRANT 
 
 
 
 
 
Date:May 15, 1995             By:/s/Kevin L. Cornwell                     
                              Kevin L. Cornwell 
                              President and CEO 
 
 
 
Date:May 15, 1995             By:/s/Kevin L. Cornwell                 
                              Kevin L. Cornwell 
                              Secretary and CFO 

EX-27

 
 
<ARTICLE>                   5 
        
                                             
<FISCAL-YEAR-END>                        DEC-31-1995 
<PERIOD-START>                           JAN-01-1995 
<PERIOD-END>                             MAR-31-1995 
<PERIOD-TYPE>                            3-MOS 
<CASH>                                   4,187,291 
<SECURITIES>                             5,148,636 
<RECEIVABLES>                            5,485,792 
<ALLOWANCES>                             (83,283) 
<INVENTORY>                              3,906,877 
<CURRENT-ASSETS>                         19,595,691 
<PP&E>                                   13,359,455 
<DEPRECIATION>                           (5,151,191) 
<TOTAL-ASSETS>                           28,671,867 
<CURRENT-LIABILITIES>                    3,499,999 
<BONDS>                                  0 
<COMMON>                                 99,193 
<PREFERRED-MANDATORY>                    0 
<PREFERRED>                              0 
<OTHER-SE>                               24,470,308 
<TOTAL-LIABILITY-AND-EQUITY>             28,671,867 
<SALES>                                  9,754,041 
<TOTAL-REVENUES>                         9,754,041 
<CGS>                                    5,382,678 
<TOTAL-COSTS>                            1,840,215 
<OTHER-EXPENSES>                         (161,275) 
<LOSS-PROVISION>                         0 
<INTEREST-EXPENSE>                       (108,371) 
<INCOME-PRETAX>                          2,800,794 
<INCOME-TAX>                             980,277 
<INCOME-CONTINUING>                      1,820,517 
<DISCONTINUED>                           0 
<EXTRAORDINARY>                          0 
<CHANGES>                                0 
<NET-INCOME>                             1,820,517 
<EPS-PRIMARY>                            0.18 
<EPS-DILUTED>                            0.18